Rethinking ovarian cancer: recommendations for improving outcomes. - Wikidata - wikimedia - TriplyDB

Rethinking ovarian cancer: recommendations for improving outcomes.

Rethinking ovarian cancer: recommendations for improving outcomes.

http://www.wikidata.org/entity/Q36050883

about

Symptoms, ultrasound imaging and biochemical markers alone or in combination for the diagnosis of ovarian cancer in women with symptoms suspicious of ovarian cancer Guidance of Signaling Activations by Cadherins and Integrins in Epithelial Ovarian Cancer Cells Genomic/Epigenomic Alterations in Ovarian Carcinoma: Translational Insight into Clinical Practice Choline Metabolism Alteration: A Focus on Ovarian Cancer Adoptive immunotherapy against ovarian cancer The Important Roles of Steroid Sulfatase and Sulfotransferases in Gynecological Diseases Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer Cellular deficiency in the RGS10 protein facilitates chemoresistant ovarian cancer In 2014, can we do better than CA125 in the early detection of ovarian cancer?Targeted drug delivery via folate receptors in recurrent ovarian cancer: a review Ovarian cancer screening--current status, future directions The molecular fingerprint of high grade serous ovarian cancer reflects its fallopian tube origin Old drug, new trick: repurposing metformin for gynecologic cancers?Clinical investigation of receptor and non-receptor tyrosine kinase inhibitors for the treatment of epithelial ovarian cancer The Notch and Wnt pathways regulate stemness and differentiation in human fallopian tube organoids.Insulin-like growth factor 2 silencing restores taxol sensitivity in drug resistant ovarian cancer Mutant p53 regulates ovarian cancer transformed phenotypes through autocrine matrix deposition.DNA methylation changes in epithelial ovarian cancer histotypes.Glutathione S-transferase P1 (GSTP1) directly influences platinum drug chemosensitivity in ovarian tumour cell lines.Antiangiogenic therapies in ovarian cancer New perspectives on targeted therapy in ovarian cancer Targeted immune therapy of ovarian cancer The ZNF304-integrin axis protects against anoikis in cancer Expression and clinical significance of the autophagy proteins BECLIN 1 and LC3 in ovarian cancer Fuling Granule, a Traditional Chinese Medicine Compound, Suppresses Cell Proliferation and TGFβ-Induced EMT in Ovarian Cancer Type-specific cell line models for type-specific ovarian cancer research Ovarian cancer cell line panel (OCCP): clinical importance of in vitro morphological subtypes The Essential Role of H19 Contributing to Cisplatin Resistance by Regulating Glutathione Metabolism in High-Grade Serous Ovarian Cancer Using heterogeneity of the patient-derived xenograft model to identify the chemoresistant population in ovarian cancer Development of nanoscale approaches for ovarian cancer therapeutics and diagnostics Flow induces epithelial-mesenchymal transition, cellular heterogeneity and biomarker modulation in 3D ovarian cancer nodules.A distance-based test of association between paired heterogeneous genomic data.Design and characterization of a combined OCT and wide field imaging falloposcope for ovarian cancer detection Malignant extracellular vesicles carrying MMP1 mRNA facilitate peritoneal dissemination in ovarian cancer.TLR-exosomes exhibit distinct kinetics and effector function.MRI reveals the in vivo cellular and vascular response to BEZ235 in ovarian cancer xenografts with different PI3-kinase pathway activity.A putative biomarker signature for clinically effective AKT inhibition: correlation of in vitro, in vivo and clinical data identifies the importance of modulation of the mTORC1 pathway.Data Mining of Gene Arrays for Biomarkers of Survival in Ovarian Cancer Effect of Pantethine on Ovarian Tumor Progression and Choline Metabolism.Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study

P2860

Q24187351-3CB10C95-69DD-4D47-A6A3-1B23A92C0BF9 Q26738643-DDCB8D9F-B21E-4491-9390-BDCB982FBDF1 Q26740622-09872DCF-B098-4B07-A138-65F7D1D12535 Q26742116-F13C09C4-E9D4-4197-8B6C-DE3620B0B267 Q26748905-8D3903DF-9CA4-4D5D-B853-FC8D42600B16 Q26765913-545ABCA1-DFE3-40B9-B2DE-DB023009EF48 Q26780387-282B53C6-8F29-4BBF-9C00-42C61EAA4999 Q26796258-133926EB-7C58-4DA5-955D-F7AC2FFAFE51 Q26825152-46C75534-0B55-412C-8AA9-035E755456FC Q26828581-CA20C671-DBA1-42C8-809F-F456C35A64BD Q27004471-44EF4CE2-1D8E-42F2-B3E7-142A262ECD54 Q27008375-17D1B96E-442A-4DCE-AE24-45FEECB518F7 Q27010558-1CDAAC05-0E15-410F-92F8-F9F58B6770F8 Q27024235-3CA94976-39C7-4D75-85BF-8FD796C1D45B Q27316757-383EA7D3-A29C-403A-BD2D-6B29EF37D5D1 Q27322873-DFC0B82A-4085-41EE-8F93-B59F81A1CDC7 Q27333756-742D42F4-0D0E-4BE9-97DE-8C4EE967397F Q27690722-1E591310-F4EF-4CA1-B6E8-DF8D7110C95F Q27853038-EC9C9C48-2C59-487B-8528-C8173050E96B Q28073722-F57AFCBF-5B9A-4C91-8C6D-91FD996A2DE7 Q28082524-DC6E2FFF-A956-44C0-AE94-CDDB57024761 Q28082828-EA2AFB3F-E7F9-45B9-A426-BCCA9BA1EEC7 Q28115264-53E8FF25-4B66-46F9-A8E1-77A741A28CEB Q28246311-E3E3DEA0-BE5B-442C-998F-E7D9C6E1F6F3 Q28468466-C43A582D-9592-4ED2-8D3C-9CF33CAA1D70 Q28536689-79F054B0-0131-4368-A87A-8DF219CA1C12 Q28543021-CD146E0E-413F-4FCB-8B7D-2B4AE9438719 Q28833833-CB0F831C-6034-4574-8DCD-2EADB00C1F11 Q30409503-D375451C-D823-478F-B775-3833E7B957CA Q30421664-63760605-0CEF-4EEC-BBC1-5365FAAFDC0C Q30446755-8E4A65C9-E361-4E7A-9CAC-6FEC932EAD3E Q30659492-2BBE152B-9F9D-4C1F-86D3-F6BBDB80607C Q30834795-C43C9AD2-E04E-4886-AA30-664907A8360A Q30841262-8267FCEC-F3B3-41D1-B9F5-770EED26B007 Q30841825-74AE363D-C720-4B08-936C-EBCBE3D9FA4E Q30881669-80C2FBA3-72DA-45C9-B418-90C6CCEFB0EC Q31010361-3E2C0212-B7FB-45E1-B788-2F5C96E406D3 Q31126996-BB74420E-560F-4636-80DB-9453943FBB19 Q31145516-F791A407-834D-4FC1-BFD5-B375BB907CBB Q33551425-B3BF25F8-0753-40C8-B225-23DF49179B91

P2860

Rethinking ovarian cancer: recommendations for improving outcomes.

http://www.wikidata.org/entity/Q36050883

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Rethinking ovarian cancer: recommendations for improving outcomes.

@ast

Rethinking ovarian cancer: recommendations for improving outcomes.

@en

type

label

Rethinking ovarian cancer: recommendations for improving outcomes.

@ast

Rethinking ovarian cancer: recommendations for improving outcomes.

@en

prefLabel

Rethinking ovarian cancer: recommendations for improving outcomes.

@ast

Rethinking ovarian cancer: recommendations for improving outcomes.

@en

P1433

Q36050883-6D596AC2-B23E-4235-B7EC-3C5CE2695853

P1476

Q36050883-75A4152D-A09A-42D3-AF63-E2E2ACC59809

P2093

Q36050883-12884FEA-F270-4BC5-B0CB-5199FD33D5C5

Q36050883-168F5238-2085-4C0B-B417-75D69E745777

Q36050883-1A671955-3944-4C48-9DC2-F01401CA6F7E

Q36050883-1BE5D0FD-EBAA-4B64-AE60-9AE81922D219

Q36050883-37E9643B-1B7A-4FCC-91EC-D903B4E7D681

Q36050883-45A4F3A8-DDF5-4E83-B9CA-358DE3D49452

Q36050883-6F2BE424-F06F-4216-AC18-8D3B5766CD01

Q36050883-7AA2E2C4-5682-40AA-8F3F-CB72D2B11F8A

Q36050883-7CFB1190-CD3C-4955-9F1C-F259449EA4AF

Q36050883-81D8040E-0D99-428F-9C17-7B4736DA9954

P2860

Q36050883-03022989-6F8F-45A7-99CD-C59E36FA1471

Q36050883-064DBACA-3D94-430A-A9ED-284D13E263EA

Q36050883-1221B2A6-31ED-4A4F-8A70-081A726758B3

Q36050883-13058E82-1D79-43C0-B755-1E504BE4A3B2

Q36050883-147C4A35-F329-414A-AE5B-85A4CAEE60E3

Q36050883-1614FDC1-C8B4-4D8A-AC89-26A6112B0B29

Q36050883-1621EFDA-427D-470B-8E30-B37284FCD630

Q36050883-166E38CE-A0C3-4B87-AA87-9581F552C429

Q36050883-1AE869DE-1453-48BD-9078-D3E72718781D

Q36050883-1CC1B9F5-635F-49D7-A5FB-AB88C3E6358A

P2888

Q36050883-8A995904-C8A7-4C8D-97E0-9500D7B21719

P304

Q36050883-1DD7444A-FA7A-4942-8E67-9086FDF0676B

P31

Q36050883-349EC3DD-4090-4FE8-9946-E51E91103A8C

P356

Q36050883-6642A6FD-1166-47C5-A690-4CC1D2386359

P407

Q36050883-79F34F01-BF0A-44C1-832B-C4A2C3F162A5

P433

Q36050883-5547F5FC-2546-4832-959C-01971B71FC16

P478

Q36050883-BCC32AC4-1840-4EAF-A371-5CB9073CCE76

P50

Q36050883-65F467D4-6987-4927-B452-98C7E05159F1

Q36050883-7454AC28-B59A-429A-90E8-4B0517D440AB

Q36050883-7AAC3B18-ABDA-4C2F-B98A-AA04FE5BACDB

Q36050883-7EE0CE71-3251-4FA8-900A-2E9EE9983571

Q36050883-8483425B-0710-495C-AE44-7AA1430C6190

Q36050883-88C558DB-EF70-4DA2-8E3F-E2FB7129197B

Q36050883-986F32A4-639D-4413-B370-C90AFD2E1549

Q36050883-C601E828-74AC-43C6-8A98-AD83BC28F4F6

Q36050883-D8543C14-97EB-4E70-91AD-6943B4181106

Q36050883-EE2DF360-0AC9-452B-B71E-604CC2A7A7B7

P577

Q36050883-31E83048-8AA6-4B1C-A8F4-22F232E52796

P5875

Q36050883-6ECED555-1A42-480D-BFD0-E0B9A81942E4

P6179

Q36050883-D31209A1-BB88-4A50-9F08-B0E82B60CA2D

P698

Q36050883-02008C3C-D87B-448E-A3DC-9E04ECCF720B

P921

Q36050883-91FF576E-A382-460A-B10D-A0CDF9AD323E

P932

Q36050883-FEF015A2-54F6-478E-A8E2-17FD0DCA0372

P356

P1433

Nature Reviews Cancer

P1476

Rethinking ovarian cancer: recommendations for improving outcomes.

@en

P2093

Amit M Oza

http://www.w3.org/2001/XMLSchema#string

Andy Berchuck

http://www.w3.org/2001/XMLSchema#string

Anil K Sood

http://www.w3.org/2001/XMLSchema#string

Chris J Lord

http://www.w3.org/2001/XMLSchema#string

Christopher C Crum

http://www.w3.org/2001/XMLSchema#string

Dariush Etemadmoghadam

http://www.w3.org/2001/XMLSchema#string

Douglas A Levine

http://www.w3.org/2001/XMLSchema#string

Euan A Stronach

http://www.w3.org/2001/XMLSchema#string

Gordon B Mills

http://www.w3.org/2001/XMLSchema#string

Hani Gabra

http://www.w3.org/2001/XMLSchema#string

P2860

Ovarian carcinoma subtypes are different diseases: implications for biomarker studies

ARID1A mutations in endometriosis-associated ovarian carcinomas

Distant metastasis occurs late during the genetic evolution of pancreatic cancer

Quantitation of circulating tumor cells in blood samples from ovarian and prostate cancer patients using tumor-specific fluorescent ligands

Effect of Screening on Ovarian Cancer Mortality

Integrated genomic analyses of ovarian carcinoma

Cancer-related inflammation

Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma

A limited panel of immunomarkers can reliably distinguish between clear cell and high-grade serous carcinoma of the ovary

Common variants at 19p13 are associated with susceptibility to ovarian cancer.

P2888

P304

719-725

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NRC3144

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

James D Brenton

Frances R Balkwill

Jermaine I Coward

P577

2011-09-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51664772

http://www.w3.org/2001/XMLSchema#string

P6179

1053036406

http://www.w3.org/2001/XMLSchema#string

P698

21941283

http://www.w3.org/2001/XMLSchema#string

P921

P932

3380637

http://www.w3.org/2001/XMLSchema#string